Studies have shown that α-synuclein-specific analyses performed in cerebrospinal fluid (CSF) can differentiate patients with PD from healthy controls with a high degree of sensitivity and specificity (Siderowf et al., 2023). Here, SNCA is linked to Parkinson disease.